RCKT
Rocket Pharmaceuticals, Inc. Common StockstockNASDAQ
Market OpenNov 19, 2026 9:44:47 AM EST
2.14USD+1.422%(+0.03)76,323
Pre-marketNov 19, 2026 8:53:30 AM EST
2.115USD+0.237%(+0.005)
RCKT Financials
In Q3 FY 2026 (ended ), Rocket Pharmaceuticals, Inc. Common Stock (RCKT) reported revenue of $0, net income of −$49.23M, operating cash flow of −$39.05M, and assets of $419.5M (filed ).
Loading financial flows…